FDA Approves Xpovio Triple Combo for Previously Treated Myeloma
News
The U.S. Food and Drug Administration (FDA) has approved a triple combination of Xpovio (selinexor) plus Velcade (bortezomib) and low-dose dexamethasone for the treatment of people with multiple myeloma ... Read more